Skip to main content
SpringerLink
Log in

Long-term effects of captopril on renal function in hypertensive patients

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effect of captopril up to 450 mg/day on blood pressure and renal function were investigated during sustained treatment of 10 patients whose severe hypertension had not responded to previous therapy. All the patients were kept on diuretics and most of them on β-blockers, too. A control determination of glomerular filtration rate (GFR) and para-aminohippuric acid clearance (CPAH) was performed during the prior treatment. The effect of the addition (or substitution) of captopril were assessed after an average of 25 days (short-term) and 26 weeks (long-term). Short-term treatment produced a 15.5% decrease in mean blood pressure and interindividually variable effects on renal function. On average GFR was somewhat lower and CPAH slightly higher than the control values (not significant). This pattern is quite similar to the effects of most other antihypertensive drugs. On long-term therapy GFR rose by a mean of 9% (NS) and CPAH by 17% (p<0.02). However, in a patient who developed a captopril-induced nephrotic syndrome, GFR dropped to 56% and CPAH to 50% of the control values. In another patient a transient rise in serum creatinine accompanied a severe drug reaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cody RJ, Tarazi RC, Bravo EL, Fouad FM (1978) Haemodynamics of orally-active converting enzyme inhibitor SQ 14225 in hypertensive patients. Clin Sci Mol Med 55: 453–459

    Google Scholar 

  2. Tarazi RC, Bravo EL, Fouad FM, Omvik P, Cody RF (1980) Hemodynamic and volume changes associated with captopril. Hypertension 2: 576–585

    Google Scholar 

  3. Antonaccio MJ, Rubin B, Horovitz ZP (1980) Effects of captopril in animal models of hypertension. Clin Exp Hypertension 2: 613–637

    Google Scholar 

  4. Zimmermann BG, Mommsen C, Kraft E (1980) Renal vasodilation caused by Captopril in conscious normotensive and Goldblatt hypertensive dogs. Proc Soc Exp Biol Med 164: 459–465

    Google Scholar 

  5. Clappison BH, Anderson WP, Johnston CI (1981) Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition. Kidney Int 20: 615–620

    Google Scholar 

  6. Murthy VS, Waldron TL, Goldberg ME (1978) Inhibition of angiotensin-converting enzyme by SQ 14, 225 in anesthetized dogs: hemodynamic and renal vascular effects. Proc Soc Exp Biol Med 157: 121–124

    Google Scholar 

  7. Duchin KL, Steinbacher TE (1978) Effects of captopril on renal function in the dog. Kidney Int 14: 693

    Google Scholar 

  8. Williams GM, Davis JO, Freeman RH, De Forrest JM, Seymour AA, Rowe BP (1979) Effects of the oral converting enzyme inhibitor SQ 14, 225 in experimental high output failure. Am J Physiol 236: F541-F545

    Google Scholar 

  9. Warren SE, Cohen IM, O'Connor DT, Cervenka J, Stone RA (1979) Heterogeneity of renal hemodynamic response to captopril. Kidney Int 16: 909

    Google Scholar 

  10. Mimran A, Brunner HR, Turini GA, Waeber B, Brunner D (1979) Effect of captopril on renal vascular tone in patients with essential hypertension. Clin Sci 57: 421S-423S

    Google Scholar 

  11. Dzau VJ, Colucci WS, Williams GH, Curfman G, Meggs L, Hollenberg NK (1980) Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med 302: 1373–1379

    Google Scholar 

  12. Röckel A, Brand A, Heidbreder E, Stürmer G, Heidland A (1980) A clinical comparison of a converting enzyme inhibitor and of hydrochlorothiazide. In: Gross F, Liedtke RK (eds) Pharmacology and clinical use of angiotensin I converting enzyme inhibitors. Fischer, Stuttgart New York, pp 82–91

    Google Scholar 

  13. Hollenberg NK, Meggs LG, Williams GH, Katz J, Garnic JD, Harrington DP (1981) Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney Int 20: 240–245

    Google Scholar 

  14. Pierpont G, Francis G, Cohn J (1981) Effect of captopril on renal function in patients with congestive heart failure. Br Heart J 46: 522–527

    Google Scholar 

  15. Pessina AC, Semplicini A, Rossi G, Gatta A, Palatini P, Gava R, Gasiglia E, Dal Palu C (1982) Effects of captopril on renal function in hypertensive patients. Am J Cardiol 49: 1572–1573

    Google Scholar 

  16. Reubi FC, Vorburger C, Bütikofer E (1970) A comparison of the short-term and long-term hemodynamic effects of antihypertensive drug therapy. In: Conolly ME (ed) Catapres in hypertension. Butterworth, London, pp 113–125

    Google Scholar 

  17. Reubi FC (1977) Le retentissement rénal des traitements antihypertenseurs. J Urol Néphrol 83: 296–302

    Google Scholar 

  18. Vorburger C, Riedwyl H, Reubi FC (1969) Vergleichende Studien zwischen den renalen Clearances von 51Cr-EDTA, Inulin and Thiosulfat beim Menschen. Klin Wochenschr 47: 415–420

    Google Scholar 

  19. Reubi FC (1963) Clearance tests in clinical medicine. CC Thomas, Springfield, Ill

    Google Scholar 

  20. Wong PC, Zimmerman BG (1982) Dependance of renal vasodilator effect of Captopril on prevailing renin level in the dog: influence of DOCA-salt treatment. Clin Sci 63: 355–360

    Google Scholar 

  21. Reubi FC (1978) Role of physical factors in the acute changes in renal function elicited by antihypertensive drugs. Eur J Clin Pharmacol 13: 185–193

    Google Scholar 

  22. Gilmore E, Weil J, Chidsey C (1970) Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade. N Engl J Med 282: 521–527

    Google Scholar 

  23. Danesh BJZ, Brunton J (1981) Nadolol and renal haemodynamics. In: Gross F: International experience with Nadolol. Royal Society of Medicine, London, pp 87–95

    Google Scholar 

  24. Onesti G, Bock KD, Heimsoth V, Kim KE, Merguet P (1971) Clonidine: a new antihypertensive agent. Am J Cardiol 28: 74–83

    Google Scholar 

  25. Bartorelli C, Gargano N, Regoli D, Zanchetti A (1960) Die Wirkung langdauernder Guanethidin-Verabreichung auf die Nierenfunktion von Hochdruckkranken. Dtsch Med Wochenschr 85: 1271–1275

    Google Scholar 

  26. Blantz RC, Konnen KS, Tucker BJ (1976) Angiotensin II effects upon glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 57: 419–434

    Google Scholar 

  27. Bradley SE, Parker B (1941) The hemodynamic effects of angiotensin in normal man. J Clin Invest 20: 715–719

    Google Scholar 

  28. Deen WM, Myers BD, Troy JL, Brenner BM (1974) Effects of vasoactive substances on the preglomerular, glomerular and postglomerular microcirculation in rats. Kidney Int 6: 35 A

    Google Scholar 

  29. Vorburger C, Lüthi H, Reubi FC (1965) Erfahrungen mit 1-α-Methyldopa (Aldomet) in der Hypertoniesprechstunde. Schweiz Med Wochenschr 95: 238–246

    Google Scholar 

  30. Bauer JH (1983) Effects of propranolol therapy on renal function and body fluid composition. Arch Int Med 143: 927–931

    Google Scholar 

  31. Reubi FC (1960) The late effects of hypotensive drug therapy on renal functions of patients with essential hypertension. In: Bock KD, Cottier PT (eds) Essential hypertension. Springer, Berlin Heidelberg New York, pp 317–331

    Google Scholar 

  32. Reubi FC (1983) Antihypertensive treatment in renal failure. In: Messerli F (ed) Kidney in essential hypertension. Martinus Nijhoff, Boston

    Google Scholar 

  33. Hoorntje SJ, Kallenberg CGM, Weening JJ, Donker AJM, The TH, Hoedemaeker PJ (1980) Immune-complex glomerulopathy in patients treated with Captopril. Lancet 1: 1212–1214

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Poliklinik, Universität Bern, Bern, Switzerland

    Z. Glück, C. Beretta-Piccoli & F. C. Reubi

Authors
  1. Z. Glück
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Beretta-Piccoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. C. Reubi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Glück, Z., Beretta-Piccoli, C. & Reubi, F.C. Long-term effects of captopril on renal function in hypertensive patients. Eur J Clin Pharmacol 26, 315–323 (1984). https://doi.org/10.1007/BF00548761

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00548761

Key words

Search

Navigation